Mallinckrodt Pharmaceuticals plc and Endo Inc. said Thursday they are combining as part of a stock-and-cash deal with an enterprise value of $6.7 billion that will give both companies a roughly 50 ...

following the close of the merger agreement. Mallinckrodt and Endo said the location of the combined company’s U.S. headquarters and its corporate name will be announced “in due course.” ...

Mallinckrodt and Endo are set to merge in a cash-and-stock deal valued at $6.7 billion, with the drug makers set to list shares of the new firm on the New York Stock Exchange.

Per deal terms, Endo shareholders will receive Mallinckrodt stock and a share of $80 million in cash. After the merger, a business made up of Endo’s sterile injectables and both companies ...

Mallinckrodt and Malvern, Pennsylvania-based Endo's predecessor company ... Upon completion of the merger, Olafsson will become CEO of the combined company, and Paul Efron, a member of the ...

(Sharecast News) - Pharmaceutical firm Mallinckrodt said on Thursday that it has agreed to merge with Endo in a $6.7bn deal. Under the terms of the agreement, Endo shareholders will receive $80m ...

Two companies forced to file for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – have agreed to join forces via a $6.7 billion merger. According to the ...

DUBLIN and MALVERN, Pa. - Mallinckrodt plc and Endo International plc announced a definitive merger agreement in a stock and cash transaction. The deal is set to create a global pharmaceuticals ...

"That helps us." Endo shareholders will get $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will own the rest for an enterprise value of $6.7 billion, the ...

March 13, 2025 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt") and Endo, Inc. (OTCQX: NDOI) ("Endo") today announced that they have entered into a definitive agreement to combine in a stock and ...